search
Back to results

Respiratory Rehabilitation for Patients With Chronic Obstructive Pulmonary Disease (REHABDO)

Primary Purpose

Chronic Obstructive Pulmonary Disease

Status
Unknown status
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
Home respiratory rehabilitation
Center respiratory rehabilitation
Sponsored by
University Hospital, Lille
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Chronic Obstructive Pulmonary Disease focused on measuring Pulmonary rehabilitation, home-based

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:According to HAS recommendations, SPLF, ERS / ATS (3) (18) (19) can be included any patient, over 18 years old, with stage II - III - IV COPD presenting disabling dyspnoea in activities of daily living, and / or in the course of acute exacerbation of COPD (EABPCO), with no other respiratory pathology diagnosed.

Exclusion Criteria:

According to the recommendations, HAS, SPLF, ERS / ATS will not be included any patient having :

  • co-morbidities including unstabilized cardiovascular disease,
  • significant cognitive disorders: patients with a history of pathologies neurodegenerative with loss of mental faculties (example: Alzheimer)
  • psychiatric disorders: patients with impaired judgment and perception
  • neurological or orthopedic disorders that do not allow the realization of physical activities

Also, will not be included, the patient (s):

  • waiting for lung transplantation,
  • pregnant or nursing,
  • in an emergency situation
  • unable to receive enlightened information,
  • unable to participate in the entire study,
  • not covered by the social security scheme,
  • refusing to sign the consent,

Sites / Locations

  • Centre hospitalier de béthuneRecruiting
  • CH de BéthuneRecruiting
  • Hôpital Calmette, CHURecruiting
  • CH de LoosRecruiting
  • CH Victor Provot, RoubaixRecruiting
  • CH de TourcoingRecruiting
  • CH de WattrelosRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Active Comparator

Arm Label

home group

center group

Arm Description

Outcomes

Primary Outcome Measures

Change from baseline the 6 minutes Stepper test at 2 months
The 6 minutes stepper test (ST6), performed on a Stepper allows to analyze the number of strokes (or steps) performed in 6 minutes

Secondary Outcome Measures

Change from baseline the 6 minutes Stepper test at 6 and 12 months
The 6 minutes stepper test (ST6), performed on a Stepper allows to analyze the number of strokes (or steps) performed in 6 minutes
Percentage of patients expressing a preference marked for home-based respiratory rehabilitation or respiratory rehabilitation in center
Cost of interventions: respiratory rehabilitation in center or at home
Change from Baseline COPD Assessment Test (CAT) at 2,6,12 months
The COPD assessment test (CAT) is a short questionnaire initially intended for assess quality of life and clinical impact of COPD
Change from Baseline Modified Medical Research Council (MMRC) Dyspnea Scale at 2,6,12 months
The scale measures a person's limitation base on a scale of 0-4 and uses the final value to determine how much disability is caused by shortness of breath.Five-option grading system called the Modified Medical Research Council (MMRC) Dyspnea Scale.
Change from Baseline Anxiety and Depression (HAD) at 2,6,12 months
To determine the levels of anxiety and depression that a COPD patients are experiencing
EPICES score
EPICES score (Assessment of the precariousness and health inequalities in the Health Examination Centers, French) is an individual indicator of precariousness ,Self-administered questionnaire,quantify the level of social vulnerability and precariousness. It ranges from zero (no vulnerability) to 100 (maximum vunerability)

Full Information

First Posted
February 16, 2018
Last Updated
August 24, 2020
Sponsor
University Hospital, Lille
Collaborators
Ministry of Health, France
search

1. Study Identification

Unique Protocol Identification Number
NCT03453606
Brief Title
Respiratory Rehabilitation for Patients With Chronic Obstructive Pulmonary Disease
Acronym
REHABDO
Official Title
Respiratory Rehabilitation at Home vs in the Center for Patients With Chronic Obstructive Pulmonary Disease: Efficacy, Preferences and Costs
Study Type
Interventional

2. Study Status

Record Verification Date
August 2020
Overall Recruitment Status
Unknown status
Study Start Date
October 24, 2018 (Actual)
Primary Completion Date
January 2022 (Anticipated)
Study Completion Date
January 2022 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University Hospital, Lille
Collaborators
Ministry of Health, France

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The aim of this clinical trial is to establish the non-inferiority of home-based respiratory rehabilitation compared to respiratory rehabilitation in center in terms of exercise tolerance as evaluated by the 6 minutes Stepper test.. This trial will also 1°) evaluate the Medico-economic aspects of the home-based Respiratory rehabilitation versus respiratory Rehabilitation in center; 2°) analyse the patient preferences between home-based respiratory rehabilitation and respiratory rehabilitation in center and 3°) Compare home-based respiratory rehabilitation vs respiratory rehabilitation in center in terms of dyspnea, quality of life, anxiety and depression.
Detailed Description
The purpose of this study is to perform a comparative analysis of the clinical and medico-economic effectiveness of center-based RR versus home-based RR in the departments of Nord and Pas de Calais in France. All COPD patients eligible for RR and willing to participate in the study will be followed. Patient preferences will be evaluated at inclusion. After presentation of both RR modalities, patients expressing a strong preference for one or other of the terms will be taken care of according to their wishes. Indifferent patients between the two RR modalities will be randomized. This design is justified in the light of three cases: It is impossible to evaluate blind intervention, The effectiveness of RR depends on patient preferences, Patients' adherence to the protocol is facilitated.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Chronic Obstructive Pulmonary Disease
Keywords
Pulmonary rehabilitation, home-based

7. Study Design

Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
670 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
home group
Arm Type
Active Comparator
Arm Title
center group
Arm Type
Active Comparator
Intervention Type
Other
Intervention Name(s)
Home respiratory rehabilitation
Intervention Description
Home care is individual (often with the spouse or the carer), during 1h30, one visit per week for 8 weeks, after completion of the educational diagnosis, under direct supervision of a member of the team, with continued physical activities in autonomy the others days of the week, according to a personalized action plan. No visit is scheduled in the pulmonologist, the general practitioner or in the rehabilitation center. The team includes pulmonologist, nurses, dietician, socio-medical beautician and a administrative assistant.
Intervention Type
Other
Intervention Name(s)
Center respiratory rehabilitation
Intervention Description
In an outpatient setting, the course is performed in groups of 6 to 8 patients, during sessions from 3 to 7 am, under the direction of health professionals, 3 to 5 times a week, for 4 to 6 weeks, for a total of 20 to 24 sessions. Internally, patients come to "complete" hospitalization for 4 weeks. This duration can be modulated according to the evolution of the patients. Supervision is carried out by the entire team including pulmonologists, nurses, physiotherapists, psychologists, activity professors adapted physicists, dietician
Primary Outcome Measure Information:
Title
Change from baseline the 6 minutes Stepper test at 2 months
Description
The 6 minutes stepper test (ST6), performed on a Stepper allows to analyze the number of strokes (or steps) performed in 6 minutes
Time Frame
At 2 months
Secondary Outcome Measure Information:
Title
Change from baseline the 6 minutes Stepper test at 6 and 12 months
Description
The 6 minutes stepper test (ST6), performed on a Stepper allows to analyze the number of strokes (or steps) performed in 6 minutes
Time Frame
at 6 months, at12 months
Title
Percentage of patients expressing a preference marked for home-based respiratory rehabilitation or respiratory rehabilitation in center
Time Frame
Baseline
Title
Cost of interventions: respiratory rehabilitation in center or at home
Time Frame
At 12 months
Title
Change from Baseline COPD Assessment Test (CAT) at 2,6,12 months
Description
The COPD assessment test (CAT) is a short questionnaire initially intended for assess quality of life and clinical impact of COPD
Time Frame
baseline, after RR (2 months); 6 months and12 months
Title
Change from Baseline Modified Medical Research Council (MMRC) Dyspnea Scale at 2,6,12 months
Description
The scale measures a person's limitation base on a scale of 0-4 and uses the final value to determine how much disability is caused by shortness of breath.Five-option grading system called the Modified Medical Research Council (MMRC) Dyspnea Scale.
Time Frame
baseline, after RR (2 months); 6 months and12 months
Title
Change from Baseline Anxiety and Depression (HAD) at 2,6,12 months
Description
To determine the levels of anxiety and depression that a COPD patients are experiencing
Time Frame
Baseline, after RR (2 months); 6 months and12 months
Title
EPICES score
Description
EPICES score (Assessment of the precariousness and health inequalities in the Health Examination Centers, French) is an individual indicator of precariousness ,Self-administered questionnaire,quantify the level of social vulnerability and precariousness. It ranges from zero (no vulnerability) to 100 (maximum vunerability)
Time Frame
baseline

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:According to HAS recommendations, SPLF, ERS / ATS (3) (18) (19) can be included any patient, over 18 years old, with stage II - III - IV COPD presenting disabling dyspnoea in activities of daily living, and / or in the course of acute exacerbation of COPD (EABPCO), with no other respiratory pathology diagnosed. Exclusion Criteria: According to the recommendations, HAS, SPLF, ERS / ATS will not be included any patient having : co-morbidities including unstabilized cardiovascular disease, significant cognitive disorders: patients with a history of pathologies neurodegenerative with loss of mental faculties (example: Alzheimer) psychiatric disorders: patients with impaired judgment and perception neurological or orthopedic disorders that do not allow the realization of physical activities Also, will not be included, the patient (s): waiting for lung transplantation, pregnant or nursing, in an emergency situation unable to receive enlightened information, unable to participate in the entire study, not covered by the social security scheme, refusing to sign the consent,
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Olivier Le rouzic, MD,PhD
Phone
3.20.44.59.48
Ext
+33
Email
olivier.lerouzic@chru-lille.fr
First Name & Middle Initial & Last Name or Official Title & Degree
Benoit Wallaert, MD,PhD
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Olivier Le Rouzic, MD,PhD
Organizational Affiliation
University Hospital, Lille
Official's Role
Principal Investigator
Facility Information:
Facility Name
Centre hospitalier de béthune
City
Béthune
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Frédéric Bart, MD
Facility Name
CH de Béthune
City
Béthune
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Fréderic Bart, MD
Facility Name
Hôpital Calmette, CHU
City
Lille
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Olivier Le Rouzic, MD
Facility Name
CH de Loos
City
Loos
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Said Benkharraz, MD
Facility Name
CH Victor Provot, Roubaix
City
Roubaix
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
François Steenhouwer, MD
Facility Name
CH de Tourcoing
City
Tourcoing
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Thirard Laurence, MD
Facility Name
CH de Wattrelos
City
Wattrelos
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Alain Strecker, MD

12. IPD Sharing Statement

Learn more about this trial

Respiratory Rehabilitation for Patients With Chronic Obstructive Pulmonary Disease

We'll reach out to this number within 24 hrs